Skip to main content

Table 2 Correlation of c-Met, Axl, and PDGFR-α protein expression with clinicopathologic parameters of patients with locally advanced and metastatic bladder cancers

From: Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer

Expression pattern Grade T status* Multiple Node (+) Survival
c-Met 0.561 0.904 0.727 0.321 0.009
Axl 0.409 0.105 0.795 0.300 0.789
PDGFR-α 0.344 0.470 0.718 0.049 0.027
c-Met & Axl 0.140 0.070 0.277 0.061 0.031
c-Met & PDGFR-α 0.184 0.686 0.957 0.802 0.011
Axl & PDGFR-α 0.439 0.585 0.762 0.369 0.049
c-Met & Axl & PDGFR-α 0.595 0.377 0.346 0.281 0.008
  1. *Statistical analysis was performed between stage pT2 (21), pT3 (27) and stage pT4 (17), according to TNM (2002) classification criteria.
  2. p value less than 0.05.